First report on the distribution of 3435C>T ABCB1/MDR1 polymorphism in healthy Bosniak population.
- Published in:
- Turkish Journal of Medical Sciences, 2016, v. 46, n. 3, p. 942, doi. 10.3906/sag-1410-22
- By:
- Publication type:
- Article
Works matching DE "P-glycoprotein genetics"
Results: 21
1
2
Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP.
- Published in:
- Molecules, 2017, v. 22, n. 4, p. 600, doi. 10.3390/molecules22040600
- By:
- Publication type:
- Article
3
Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population.
- Published in:
- Molecular Biology Reports, 2014, v. 41, n. 5, p. 3135, doi. 10.1007/s11033-014-3173-y
- By:
- Publication type:
- Article
4
Neurodegeneration Caused by Polyglutamine Expansion Is Regulated by P-Glycoprotein in Drosophila melanogaster.
- Published in:
- Genetics, 2013, v. 195, n. 3, p. 857, doi. 10.1534/genetics.113.155077
- By:
- Publication type:
- Article
5
Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells.
- Published in:
- Oncology Letters, 2014, v. 8, n. 4, p. 1778, doi. 10.3892/ol.2014.2337
- By:
- Publication type:
- Article
6
Astrocyte-mediated regulation of multidrug resistance P-glycoprotein in fetal and neonatal brain endothelial cells: age-dependent effects.
- Published in:
- Physiological Reports, 2016, v. 4, n. 16, p. n/a, doi. 10.14814/phy2.12853
- By:
- Publication type:
- Article
7
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
8
ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide.
- Published in:
- DNA & Cell Biology, 2019, v. 38, n. 5, p. 485, doi. 10.1089/dna.2018.4583
- By:
- Publication type:
- Article
9
Regulation Exerted by miRNAs in the Promoter and UTR Sequences: MDR1/P-gp Expression as a Particular Case.
- Published in:
- DNA & Cell Biology, 2012, v. 31, n. 8, p. 1358, doi. 10.1089/dna.2012.1703
- By:
- Publication type:
- Article
10
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.
- Published in:
- Clinical Pharmacokinetics, 2015, v. 54, n. 7, p. 709, doi. 10.1007/s40262-015-0267-1
- By:
- Publication type:
- Article
11
Modulation of multidrug resistance 1 expression and function in retinoblastoma cells by curcumin.
- Published in:
- Journal of Pharmacology & Pharmacotherapeutics, 2013, v. 4, n. 2, p. 103, doi. 10.4103/0976-500X.110882
- By:
- Publication type:
- Article
12
Comparison of <sup>99m</sup>Tc-Tetrofosmin and <sup>99m</sup>Tc-Sestamibi Uptake in Glioma Cell Lines: The Role of P-Glycoprotein Expression.
- Published in:
- International Journal of Molecular Imaging, 2014, p. 1, doi. 10.1155/2014/471032
- By:
- Publication type:
- Article
13
Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease.
- Published in:
- International Journal of Immunogenetics, 2020, v. 47, n. 6, p. 539, doi. 10.1111/iji.12511
- By:
- Publication type:
- Article
14
Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia.
- Published in:
- Pharmacogenomics Journal, 2014, v. 14, n. 5, p. 452, doi. 10.1038/tpj.2014.6
- By:
- Publication type:
- Article
15
Establishment of a cell line for assessing drugs as canine P-glycoprotein substrates: proof of principle.
- Published in:
- Journal of Veterinary Pharmacology & Therapeutics, 2017, v. 40, n. 5, p. 545, doi. 10.1111/jvp.12390
- By:
- Publication type:
- Article
16
Smilax glabra Rhizoma affects the pharmacokinetics and tissue distribution of methotrexate by increasing the P‑glycoprotein mRNA expression in rats after oral administration.
- Published in:
- Molecular Medicine Reports, 2017, v. 16, n. 5, p. 7633, doi. 10.3892/mmr.2017.7559
- By:
- Publication type:
- Article
17
Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P-glycoprotein expression.
- Published in:
- Molecular Medicine Reports, 2013, v. 8, n. 6, p. 1883, doi. 10.3892/mmr.2013.1742
- By:
- Publication type:
- Article
18
The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms.
- Published in:
- Advances in Interventional Cardiology / Postępy w Kardiologii Interwencyjnej, 2021, v. 17, n. 2, p. 179, doi. 10.5114/aic.2021.106894
- By:
- Publication type:
- Article
19
Effects of Fluvastatin on the Pharmacokinetics of Repaglinide: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Fluvastatin.
- Published in:
- Korean Journal of Physiology & Pharmacology, 2013, v. 17, n. 3, p. 245, doi. 10.4196/kjpp.2013.17.3.245
- By:
- Publication type:
- Article
20
Negative impact of FLT3-ITD mutation on expression of MDR-1 mRNA in adult acute myeloid leukemia.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 12, p. 2523, doi. 10.3109/10428194.2012.694431
- By:
- Publication type:
- Article
21
Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole.
- Published in:
- Xenobiotica, 2014, v. 44, n. 10, p. 926, doi. 10.3109/00498254.2014.901585
- By:
- Publication type:
- Article